Docking studies on monoamine oxidase-B inhibitors: Estimation of inhibition constants (Ki) of a series of experimentally tested compounds

Bioorganic & Medicinal Chemistry Letters
2005.0

Abstract

Monoamine oxidase (EC1.4.3.4; MAO) is a mitochondrial outer membrane flavoenzyme that catalyzes the oxidation of biogenic amines. It has two distinct isozymic forms designated MAO-A and MAO-B, each displaying different substrate and inhibitor specificities. They are the well-known targets for antidepressant and neuroprotective drugs. Elucidation of the X-ray crystallographic structure of MAO-B has opened the way for molecular modeling studies. A series of experimentally tested (1-10) model compounds has been docked computationally to the active site of the MAO-B enzyme. The AutoDock 3.0.5 program was employed to perform automated molecular docking. The free energies of binding (DeltaG) and inhibition constants (K(i)) of the docked compounds were calculated by the Lamarckian Genetic Algorithm (LGA) of AutoDock 3.0.5. Excellent to good correlations between the calculated and experimental K(i) values were obtained.

Knowledge Graph

Similar Paper

Docking studies on monoamine oxidase-B inhibitors: Estimation of inhibition constants (Ki) of a series of experimentally tested compounds
Bioorganic & Medicinal Chemistry Letters 2005.0
Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives
European Journal of Medicinal Chemistry 2011.0
Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors
Bioorganic & Medicinal Chemistry 2009.0
A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors
Bioorganic & Medicinal Chemistry 2010.0
2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors
Bioorganic & Medicinal Chemistry 2010.0
Chromenylchalcones with inhibitory effects on monoamine oxidase B
Bioorganic & Medicinal Chemistry 2013.0
New coumarin derivatives: Design, synthesis and use as inhibitors of hMAO
Bioorganic & Medicinal Chemistry 2014.0
Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies
Bioorganic & Medicinal Chemistry 2010.0
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold
European Journal of Medicinal Chemistry 2016.0
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase
European Journal of Medicinal Chemistry 2010.0